Digital off-axis holography with coherence-domain depth gating is able to measure sub-cellular motion inside tumors responding to cytoskeletal anti-cancer drugs.
motility are performed on two-dimensional (2D) cell cultures, but these lack the natural three dimensional (3D) environment of cellular tissue. This dimensionality reduction affects how the cells communicate, and how they respond to stimuli [1] . For this reason, many conventional microscopies have moved to 3D using confocal and nonlinear probes, but there has not been an equivalent move in the field of cellular motility. By combining digital holography with coherence-domain depth gating in a technique called holographic optical coherence imaging (HOCI), we provide an optical imaging approach that extracts sub-cellular motion as deep as 1 mm inside living tissue from cells in their natural 3D environment.
Coherence-Domain Imaging with Digital Holography
Holographic optical coherence imaging is a hybrid technique that uses the depthselective advantages of coherence-domain imaging [2] [3] combined with the advantages of digital microscopy [4] . Digital off-axis holography provides a natural approach for coherence detection using spatial heterodyne in a similar manner to temporal or spectral heterodyne used in optical coherence tomography (OCT). The capture of a full frame on a digital CCD carries with it a multiplex advantage for improved signal-to-noise performance that offsets finite bit depth on the camera pixels.
We work in a Fourier-domain holography configuration in which the hologram is recorded by the CCD array placed at the Fourier plane of the imaging system [5] [6] , as shown in Fig. 1 . Image demodulation is accomplished through a simple fast Fourier transform (FFT) that yields both the amplitude and phase of the object through the combination of complex-conjugate image pairs. Our Fourier approach is somewhat simpler than Fresnel approaches [7] , and is compatible with large depth-of-focus (roughly half a millimeter) at low magnification. Our interest is in statistical measurements of cellular motility rather than in microscopic imaging, and so a large field-of-view works to our advantage.
Living tissue represents a volumetric diffuse target that behaves substantially differently than specular two-dimensional targets that are commonly used in digital holography. When performing holography on 2D targets using short-coherence light, fringe walk-off on the hologram is a problem that affects the field of view [8] . However, with a volumetric scattering target like translucent tissue, there is no coherence-volume walk-off effect. The effect of wavefront-matching with the reference beam, in this case, simply tilts the optical section by an angle equal to the crossing angle of the signal and reference beams, while retaining full field of view. Furthermore, when performing Fourier-domain holography on specular targets, the intensity dynamic range tends to be too large for the digital bit depth of CCD cameras. However, with a diffuse target like tissue, the Fourier plane is broadly illuminated, eliminating this problem. Therefore, diffuse volumetric targets are ideal for performing digital short-coherence Fourierdomain holography.
The target tissue that we work with are multicellular tumor spheroids [9] . These are small spherical tumors that are grown in a bioreactor from a cancerous cell line. We use a rat osteogenic sarcoma cell line that grows into spheroids with diameters up to 1 mm with a well-defined morphology that consists of an outer shell of proliferating cells in communication with the oxygen and nutrients of the growth medium, surrounding a necrotic inner core of apoptotic and dead cells with voids of extracellular debris and microcalcifications. This well-defined spatial morphology of the tumor spheroids make them ideal targets by presenting both living and necrotic tissue as well as spatially varying structure to test the imaging modality.
The reconstructed digital holograms of the tumors are highly speckled. This arises from the fact that the illumination is broad field, constituting a large number of optical modes. Cross-talk among the many modes leads to fully-developed speckle.
Speckle in biomedical imaging is almost universally regarded as a parasitic effect, with many approaches focusing on speckle reduction techniques. However, in our case, this speckle is not parasitic, but is the actual source of our imaging contrast that seeks to highlight cellular motility.
Shimmering Holograms
The most striking feature of our speckle holograms of living tissue is how dynamic they are. If successive holograms are acquired at a fixed depth, there is significant variability from frame to frame. This is immediately evident in the Movie in This dynamic tissue area coincides with the shell of healthy proliferating cells.
We have defined several different motility metrics to quantify the time-dependent speckle variability. For instance, the time autocorrelation function can be constructed for each pixel from which correlation times and strengths can be extracted that relate to cellular motion. However, our simplest and most robust motility metric is the normalized standard deviation (NSD). We take a number of frames at a fixed depth and calculate the NSD for each pixel. We repeat this process for multiple depths and can build up a data volume in which each voxel has a level of cellular motility. A 3D visualization of the motility in a tumor spheroid is shown in Fig. 3 . The healthy outer shell is red and orange in the false-color rendering representing high motility, surrounding a blue low-motility necrotic core. This motility image has high contrast, showing clearly those areas of the tumor that have active cellular motion contrasted with the inactive necrotic core. This data analysis from the holographic dynamic speckle represents a novel imaging modality with a novel contrast agent. This motility contrast is highly specific to stimuli or assaults on the tumor that directly affect cellular motion. Because of the essential role that the cellular cytoskeleton plays in cellular motility, we focus on how the tissue motility responds to cytoskeletal anti-cancer drugs.
Response to Anti-Mitotic Drugs
Anti-mitotic drugs (AMDs) are common anti-cancer agents that disrupt mitosis.
Because cancer cells have un-checked cell cycles, attacking the mitotic process can preferentially affect cancerous cells. The most common AMDs affect the cytoskeleton, consisting of microtubules and actin filaments, because of its central role in the mechanical processes of cell division. We have studied 4 cytoskeletal drugs, each that attack the cytoskeleton, but with differing mechanisms and differing potency. Colchicine is a natural drug derived from the autumn crocus that inhibits tubulin polymerization.
Nocodazole is a synthetic drug that works in a similar manner, but with greater potency. This difference between the microtubule inhibition and stabilization highlights the specificity of motility as an imaging contrast agent. Although both nocodazaole and taxol are both potent anti-mitotic drugs, only nocodazole shows marked suppression of the motility.
Conclusions and Future Work
In conclusion, we have developed a new imaging modality that uses cellular motility as a novel contrast agent. Our sensitivity to cellular motility is high, making it possible to clearly distinguish between normal healthy tissue and necrotic tissue. It also enables us to track the time response to drug doses that affect organelle motion. These data are obtained deep (up to 1 mm) inside the tissue at a range inaccessible to any other imaging technique. We furthermore have displacement sensitivity that is a small fraction of a wavelength, while supporting a field-of-view of many millimeters. The dynamic range of smallest displacement ratioed to field-of-view is approximately a million to one: which is several orders of magnitude larger than any conventional microscopy, even interferometric microscopy. Such new capabilities, beyond current conventional approaches, are likely to suggest new applications in the field of cell-or tissue-based assays.
For the future, the specificity of the motility contrast provides a clear distinction between those applications that can benefit from this approach, and those that cannot.
There can be many causative factors that modify cellular motility, yet motility contrast alone cannot distinguish among them. Therefore, what is needed is another handle on cellular mechanisms that can help separate causes and effects. One such handle is to separate out the mitotic events from general cellular motility. This would be important because the next generation of anti-mitotic drugs is targeted specifically to cells in the mitotic phase of the cell cycle. These drugs do not affect quiescent undividing cells, unlike the current AMDs that affect the cytoskeleton in normal and cancer cells alike.
Therefore, tracking cell division in the tumor spheroids would provide a means to testing the efficacy of a new drug in arresting the cell cycle. In the mitotic phase, the stages of metaphase and cytokinesis are highly dynamic, in which large-scale motion takes place, mediated by the microtubules in the first case, and actin filaments in the second case.
These phases would yield high-amplitude, low-probability events in the probabilistic distribution of speckle intensity jumps. The location of "large event pixels" within the dynamic speckle may allow localization of highly dynamic cells during mitosis. The statistical and spatial distribution of these events could potentially be correlated with the activity of AMD's. Fig. 1 Schematic of the digital holographic optical coherence imaging system. The CCD camera is located at the Fourier plane of the imaging optics. The low-coherence light source is a Ti:Sapphire laser operating at a wavelength of 840 nm with a coherence length of 30 microns that sets the depth resolution of the system. The depth is selected by adjusting the relative delay between the signal and reference waves. 
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